A detailed history of Geode Capital Management, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 432,762 shares of PMVP stock, worth $649,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
432,762
Previous 427,724 1.18%
Holding current value
$649,143
Previous $692,000 6.94%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.44 - $1.69 $7,254 - $8,514
5,038 Added 1.18%
432,762 $644,000
Q2 2024

Aug 09, 2024

SELL
$1.51 - $2.21 $717,873 - $1.05 Million
-475,413 Reduced 52.64%
427,724 $692,000
Q1 2024

May 13, 2024

BUY
$1.51 - $3.12 $64,629 - $133,539
42,801 Added 4.97%
903,137 $1.54 Million
Q4 2023

Feb 13, 2024

BUY
$1.23 - $6.6 $64,910 - $348,301
52,773 Added 6.53%
860,336 $2.67 Million
Q3 2023

Nov 13, 2023

BUY
$6.01 - $8.93 $373,996 - $555,704
62,229 Added 8.35%
807,563 $4.96 Million
Q2 2023

Aug 11, 2023

BUY
$3.94 - $6.27 $312,138 - $496,728
79,223 Added 11.89%
745,334 $4.67 Million
Q1 2023

May 15, 2023

BUY
$4.77 - $9.16 $76,014 - $145,973
15,936 Added 2.45%
666,111 $3.18 Million
Q4 2022

Feb 13, 2023

BUY
$8.17 - $12.95 $41,127 - $65,190
5,034 Added 0.78%
650,175 $5.66 Million
Q3 2022

Nov 14, 2022

BUY
$11.4 - $17.18 $907,531 - $1.37 Million
79,608 Added 14.08%
645,141 $7.68 Million
Q2 2022

Aug 12, 2022

BUY
$9.23 - $22.43 $1.04 Million - $2.54 Million
113,030 Added 24.98%
565,533 $8.06 Million
Q1 2022

May 13, 2022

SELL
$14.86 - $23.55 $86,559 - $137,178
-5,825 Reduced 1.27%
452,503 $9.42 Million
Q4 2021

Feb 11, 2022

BUY
$19.99 - $30.24 $496,851 - $751,615
24,855 Added 5.73%
458,328 $10.6 Million
Q3 2021

Nov 12, 2021

BUY
$26.84 - $36.58 $2.29 Million - $3.12 Million
85,292 Added 24.5%
433,473 $12.9 Million
Q2 2021

Aug 13, 2021

BUY
$28.01 - $36.01 $2.86 Million - $3.68 Million
102,095 Added 41.49%
348,181 $11.9 Million
Q1 2021

May 12, 2021

BUY
$30.66 - $49.5 $7,419 - $11,979
242 Added 0.1%
246,086 $8.09 Million
Q4 2020

Feb 12, 2021

BUY
$31.86 - $61.51 $6.78 Million - $13.1 Million
212,844 Added 644.98%
245,844 $15.1 Million
Q3 2020

Nov 13, 2020

BUY
$35.5 - $38.0 $1.17 Million - $1.25 Million
33,000 New
33,000 $1.17 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $68.4M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.